Trial intelligence / Profile preview

Inhaled Dry Powder Mannitol in Cystic Fibrosis

NCT00446680Phase 3Completed

Sponsor
Syntara Limited
Start
Mar 2007
Primary completion
May 2010
Modality
Inhalation Devices, Small Molecules
Countries
3
01

Overview

A Phase 3 trial of Bronchitol in cystic fibrosis (CF), sponsored by Syntara Limited. Started Mar 2007; status: completed.

02

Drugs

Bronchitol
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00446680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00446680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call